These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 20677335)

  • 21. Profiles of Lamina Propria T Helper Cell Subsets Discriminate Between Ulcerative Colitis and Crohn's Disease.
    Li J; Ueno A; Fort Gasia M; Luider J; Wang T; Hirota C; Jijon HB; Deane M; Tom M; Chan R; Barkema HW; Beck PL; Kaplan GG; Panaccione R; Qian J; Iacucci M; Gui X; Ghosh S
    Inflamm Bowel Dis; 2016 Aug; 22(8):1779-92. PubMed ID: 27243594
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Distinct patterns of naive, activated and memory T and B cells in blood of patients with ulcerative colitis or Crohn's disease.
    Rabe H; Malmquist M; Barkman C; Östman S; Gjertsson I; Saalman R; Wold AE
    Clin Exp Immunol; 2019 Jul; 197(1):111-129. PubMed ID: 30883691
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mucosal T-cell immunoregulation varies in early and late inflammatory bowel disease.
    Kugathasan S; Saubermann LJ; Smith L; Kou D; Itoh J; Binion DG; Levine AD; Blumberg RS; Fiocchi C
    Gut; 2007 Dec; 56(12):1696-705. PubMed ID: 17682002
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intestinal CD103+CD4+ and CD103+CD8+ T-Cell Subsets in the Gut of Inflammatory Bowel Disease Patients at Diagnosis and During Follow-up.
    Roosenboom B; Wahab PJ; Smids C; Groenen MJM; van Koolwijk E; van Lochem EG; Horjus Talabur Horje CS
    Inflamm Bowel Dis; 2019 Aug; 25(9):1497-1509. PubMed ID: 30918941
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Suppressive and Gut-Reparative Functions of Human Type 1 T Regulatory Cells.
    Cook L; Stahl M; Han X; Nazli A; MacDonald KN; Wong MQ; Tsai K; Dizzell S; Jacobson K; Bressler B; Kaushic C; Vallance BA; Steiner TS; Levings MK
    Gastroenterology; 2019 Dec; 157(6):1584-1598. PubMed ID: 31513797
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunoregulatory Pathways Involved in Inflammatory Bowel Disease.
    Fonseca-Camarillo G; Yamamoto-Furusho JK
    Inflamm Bowel Dis; 2015 Sep; 21(9):2188-93. PubMed ID: 26111210
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Th17 cytokines and their emerging roles in inflammation and autoimmunity.
    Fouser LA; Wright JF; Dunussi-Joannopoulos K; Collins M
    Immunol Rev; 2008 Dec; 226():87-102. PubMed ID: 19161418
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of regulatory T cell in the pathogenesis of inflammatory bowel disease.
    Yamada A; Arakaki R; Saito M; Tsunematsu T; Kudo Y; Ishimaru N
    World J Gastroenterol; 2016 Feb; 22(7):2195-205. PubMed ID: 26900284
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Absence of a role for interleukin-13 in inflammatory bowel disease.
    Biancheri P; Di Sabatino A; Ammoscato F; Facciotti F; Caprioli F; Curciarello R; Hoque SS; Ghanbari A; Joe-Njoku I; Giuffrida P; Rovedatti L; Geginat J; Corazza GR; MacDonald TT
    Eur J Immunol; 2014 Feb; 44(2):370-85. PubMed ID: 24338958
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Naïve T cells correlate with mucosal healing in patients with inflammatory bowel disease.
    Karlsson M; Linton L; Lampinen M; Karlén P; Glise H; Befrits R; Janczewska I; Carlson M; Winqvist O; Eberhardson M
    Scand J Gastroenterol; 2014 Jan; 49(1):66-74. PubMed ID: 24188321
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Il-21 enhances NK cell activation and cytolytic activity and induces Th17 cell differentiation in inflammatory bowel disease.
    Liu Z; Yang L; Cui Y; Wang X; Guo C; Huang Z; Kan Q; Liu Z; Liu Y
    Inflamm Bowel Dis; 2009 Aug; 15(8):1133-44. PubMed ID: 19322899
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Core Fucosylation on T Cells, Required for Activation of T-Cell Receptor Signaling and Induction of Colitis in Mice, Is Increased in Patients With Inflammatory Bowel Disease.
    Fujii H; Shinzaki S; Iijima H; Wakamatsu K; Iwamoto C; Sobajima T; Kuwahara R; Hiyama S; Hayashi Y; Takamatsu S; Uozumi N; Kamada Y; Tsujii M; Taniguchi N; Takehara T; Miyoshi E
    Gastroenterology; 2016 Jun; 150(7):1620-1632. PubMed ID: 26965517
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multigene analysis unveils distinctive expression profiles of helper T-cell-related genes in the intestinal mucosa that discriminate between ulcerative colitis and Crohn's disease.
    Iboshi Y; Nakamura K; Ihara E; Iwasa T; Akiho H; Harada N; Nakamuta M; Takayanagi R
    Inflamm Bowel Dis; 2014 Jun; 20(6):967-77. PubMed ID: 24739631
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of the IL23/IL17 Pathway in Crohn's Disease.
    Schmitt H; Neurath MF; Atreya R
    Front Immunol; 2021; 12():622934. PubMed ID: 33859636
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Decade of Th9 Cells: Role of Th9 Cells in Inflammatory Bowel Disease.
    Vyas SP; Goswami R
    Front Immunol; 2018; 9():1139. PubMed ID: 29881387
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Manipulation of cytokines in the management of patients with inflammatory bowel disease.
    Monteleone G; MacDonald TT
    Ann Med; 2000 Nov; 32(8):552-60. PubMed ID: 11127933
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regulation of gut inflammation and th17 cell response by interleukin-21.
    Fina D; Sarra M; Fantini MC; Rizzo A; Caruso R; Caprioli F; Stolfi C; Cardolini I; Dottori M; Boirivant M; Pallone F; Macdonald TT; Monteleone G
    Gastroenterology; 2008 Apr; 134(4):1038-48. PubMed ID: 18395085
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Type 1 T-helper cell predominance and interleukin-12 expression in the gut of patients with Crohn's disease.
    Parronchi P; Romagnani P; Annunziato F; Sampognaro S; Becchio A; Giannarini L; Maggi E; Pupilli C; Tonelli F; Romagnani S
    Am J Pathol; 1997 Mar; 150(3):823-32. PubMed ID: 9060820
    [TBL] [Abstract][Full Text] [Related]  

  • 39. T helper cell 1-type CD4+ T cells, but not B cells, mediate colitis in interleukin 10-deficient mice.
    Davidson NJ; Leach MW; Fort MM; Thompson-Snipes L; Kühn R; Müller W; Berg DJ; Rennick DM
    J Exp Med; 1996 Jul; 184(1):241-51. PubMed ID: 8691138
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased prevalence of circulating novel IL-17 secreting Foxp3 expressing CD4+ T cells and defective suppressive function of circulating Foxp3+ regulatory cells support plasticity between Th17 and regulatory T cells in inflammatory bowel disease patients.
    Ueno A; Jijon H; Chan R; Ford K; Hirota C; Kaplan GG; Beck PL; Iacucci M; Fort Gasia M; Barkema HW; Panaccione R; Ghosh S
    Inflamm Bowel Dis; 2013 Nov; 19(12):2522-34. PubMed ID: 24097227
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.